Apnicaf Oral Solution
Prescription Required
Product introduction
Apnicaf Oral Solution is a prescription medicine used in the treatment of apnea (a disorder in which breathing repeatedly stops and starts) of prematurity. It facilitates normal breathing and reduces interrupted breathing in premature newborns.
It is used in migraine.
It is used in migraine.
Uses of Apnicaf Oral Solution
- Apnea of prematurity
Side effects of Apnicaf Oral Solution
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Apnicaf
- Restlessness
- Headache
- Dizziness
- Increased heart rate
- Insomnia (difficulty in sleeping)
How to use Apnicaf Oral Solution
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Apnicaf Oral Solution may be taken with or without food, but it is better to take it at a fixed time.
How Apnicaf Oral Solution works
Apnicaf Oral Solution is a stimulant. It works by blocking the action of certain natural substances (adenosine and phosphodiesterase) leading to stimulation of the brain and respiratory system in premature newborns. This reduces the number of episodes of interrupted breathing and helps the newborns breathe on their own.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Apnicaf Oral Solution.
Pregnancy
CONSULT YOUR DOCTOR
Apnicaf Oral Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CAUTION
Apnicaf Oral Solution should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving
UNSAFE
Apnicaf Oral Solution may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CONSULT YOUR DOCTOR
There is limited information available on the use of Apnicaf Oral Solution in patients with kidney disease. Please consult your doctor.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Apnicaf Oral Solution in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Apnicaf Oral Solution helps in the treatment of interrupted breathing in premature babies.
- If you are breast-feeding while your infant is treated with Apnicaf Oral Solution, do not drink coffee or take any other high caffeine product as caffeine passes into breast milk.
Fact Box
Chemical Class
Xanthine Derivative
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Adenosine receptor (A1 & A2) antagonist
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- O’Brien CP. Drug Addiction. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 663.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 179-83.
- Tulane University: School of Medicine. Caffeine. [Accessed 29 Jan. 2019] (online) Available from:
- Drugs.com. Caffeine Pregnancy and Breastfeeding Warnings. [Accessed 20 Mar. 2019] (online) Available from:
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Caffeine. [Updated 2019 Jun 30]. [Accessed 20 Feb. 2020] (online) Available from:
- Caffeine. Harold Hill: Macarthys Laboratories Limited; 2011 [revised 8 Aug. 2018]. (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 20 Mar. 2019] (online) Available from:
Marketer details
Name: Abbott
Address: 16th Floor, Godrej BKC, Plot – C, “G” Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
10 people viewed this recentlyMRP
₹714.59
Inclusive of all taxes
3.0 ml in 1 vial
SOLD OUT
Variants (2)
Notify me